[Effects of thromboxane on pulmonary arterial response to platelet activating factor in rabbit]. 1995

K Enzan, and H Komatsu, and K Shoji, and M Suzuki
Department of Emergency Medicine, Akita University School of Medicine.

The aim of this study is to clarify whether thromboxane mediates hemodynamic and airway changes induced by PAF in rabbits. Rabbits were divided into 4 groups. In No group rabbits (n = 5), PAF was intravenously injected. In Indo group rabbits (n = 5), indomethacin was infused intravenously 20 min prior to PAF administration. In KT2 group rabbits (n = 4), selective thromboxane antagonist; KT2-962, or in CV group rabbits (n = 3), selective PAF antagonist; CV6209 was injected intravenously 5 min prior to PAF administration. After PAF administration, pulmonary arterial and airway pressures increased transiently, and blood pressure, and leukocyte as well as platelet counts decreased. These hemodynamic and airway changes induced by PAF were almost totally blocked by CV6209 administration, but not by indomethacin and KT2-962 administrations. Similarly, decreases in leukocyte and platelet counts induced by PAF were blocked by CV6209 and KT2-962, but not by indomethacin. We conclude that thromboxane does not mediate hemodynamic and airway changes induced by PAF. PAF is likely to directly induce these changes.

UI MeSH Term Description Entries
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D011651 Pulmonary Artery The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D000403 Airway Resistance Physiologically, the opposition to flow of air caused by the forces of friction. As a part of pulmonary function testing, it is the ratio of driving pressure to the rate of air flow. Airway Resistances,Resistance, Airway,Resistances, Airway
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013928 Thromboxane A2 An unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance (RCS). Rabbit Aorta Contracting Substance,A2, Thromboxane

Related Publications

K Enzan, and H Komatsu, and K Shoji, and M Suzuki
July 1993, The American review of respiratory disease,
K Enzan, and H Komatsu, and K Shoji, and M Suzuki
May 1990, The Journal of pharmacology and experimental therapeutics,
K Enzan, and H Komatsu, and K Shoji, and M Suzuki
May 1995, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
K Enzan, and H Komatsu, and K Shoji, and M Suzuki
February 1983, Experimental and molecular pathology,
K Enzan, and H Komatsu, and K Shoji, and M Suzuki
April 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation,
K Enzan, and H Komatsu, and K Shoji, and M Suzuki
September 1988, The American journal of physiology,
K Enzan, and H Komatsu, and K Shoji, and M Suzuki
June 1992, Clinical science (London, England : 1979),
K Enzan, and H Komatsu, and K Shoji, and M Suzuki
January 1992, Respiration physiology,
K Enzan, and H Komatsu, and K Shoji, and M Suzuki
March 1999, Journal of physiology and biochemistry,
K Enzan, and H Komatsu, and K Shoji, and M Suzuki
June 2005, International journal of urology : official journal of the Japanese Urological Association,
Copied contents to your clipboard!